Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$41.26 - $51.35 $1.32 Million - $1.64 Million
32,000 Added 77.66%
73,205 $3.25 Million
Q3 2021

Nov 12, 2021

SELL
$43.79 - $55.78 $50,446 - $64,258
-1,152 Reduced 2.72%
41,205 $2.3 Million
Q2 2021

Aug 12, 2021

BUY
$36.86 - $44.5 $298,344 - $360,183
8,094 Added 23.62%
42,357 $1.81 Million
Q4 2020

Feb 11, 2021

BUY
$41.72 - $51.34 $29,746 - $36,605
713 Added 2.13%
34,263 $1.6 Million
Q3 2020

Nov 13, 2020

BUY
$37.02 - $51.28 $68,412 - $94,765
1,848 Added 5.83%
33,550 $1.43 Million
Q2 2020

Aug 12, 2020

BUY
$43.24 - $55.02 $560,001 - $712,564
12,951 Added 69.07%
31,702 $1.52 Million
Q4 2019

Feb 07, 2020

BUY
$54.32 - $64.31 $536,301 - $634,932
9,873 Added 111.21%
18,751 $1.13 Million
Q1 2019

May 10, 2019

BUY
$38.66 - $51.82 $53,273 - $71,407
1,378 Added 18.37%
8,878 $448,000
Q3 2018

Nov 09, 2018

SELL
$66.65 - $83.86 $246,605 - $310,282
-3,700 Reduced 33.04%
7,500 $520,000
Q2 2018

Aug 10, 2018

SELL
$51.25 - $76.62 $1.01 Million - $1.51 Million
-19,700 Reduced 63.75%
11,200 $847,000
Q1 2018

May 14, 2018

BUY
$52.16 - $66.86 $244,213 - $313,038
4,682 Added 17.86%
30,900 $1.63 Million
Q4 2017

Feb 13, 2018

BUY
$49.6 - $60.87 $1.3 Million - $1.6 Million
26,218
26,218 $1.4 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.